Stock earnings page

Adagio Medical Holdings, Inc (ADGM)

Track the next or latest earnings date for Adagio Medical Holdings, Inc, review consensus estimates, and see cached AI analysis for recent quarterly results.

View this earnings week Open in the app

Recent earnings news

ADGM posts 57% increase in assets under management in first quarter | The National
www.thenationalnews.com · 5 days ago

Performance reflects 'growing global relevance of Abu Dhabi’s financial ecosystem', chairman says

Why Is Adagio Medical Stock Gaining Monday? - Adagio Medical Holdings (NASDAQ:ADGM) - Benzinga
www.benzinga.com · 1 month ago

Adagio Medical shares rise after vCLAS trial shows strong VT outcomes, reduced drug use, and lower readmissions ahead of FDA review.

Archer-Daniels-Midland stock (US0394831020): earnings beat keeps focus on recovery after accounting
www.ad-hoc-news.de · 3 days ago

Archer-Daniels-Midland has recently topped quarterly earnings expectations while investors continue to watch the fallout from an internal accounting investigation, a paused buyback and a reset profit outlook.

ADGM’s FSRA, Hellenic Capital Market Commission sign deal to strengthen cross-border regulatory cooperation
www.zawya.com · 2 days ago

The MoU provides a practical framework for the FSRA and HCMC to work together on the supervision and regulation of capital markets

ADM raises 2026 earnings guidance based on ‘robust’ Q1
www.feedstuffs.com · 2 weeks ago

Updated outlook reflects expected earnings improvement primarily in crushing and ethanol due to finalized 2026 and 2027 RVOs.

Latest earnings date

Mar 18, 2026

Time not specified

Fiscal quarter: 2025-12-31

EPS estimate: N/A

Revenue estimate: N/A

Market cap: $22.66M

AI earnings summary

ADM provided 2026 adjusted EPS outlook of approximately $3.60 to $4.25, with the range dependent on U.S. biofuel policy clarity and crush margin expansion. The company expects segment operating profit growth for AS&O and relatively flat performance for Carbohydrate Solutions, while Nutrition is expected to continue stronger organic growth.

Sentiment and reaction

NEUTRAL

Sentiment score: +60.00%

Post-earnings price reaction: N/A

EPS

Estimate: N/A

Actual: $0.94

Surprise: N/A

Revenue

Estimate: N/A

Actual: N/A

Surprise: N/A

Recent earnings history

Browse the calendar week

Date	Quarter	Report window	EPS est.	Revenue est.
Mar 18, 2026	2025-12-31	Time not specified	N/A	N/A
Feb 11, 2026	Dec/2025	Time not specified	N/A	N/A